What You Should Know: InSilico Medicine, a clinical-stage company utilizing generative artificial intelligence (AI) for drug discovery, reveals the development of an orally bioavailable preclinical candidate compound. This compound targets KIF18A and aims to treat…
Continue Reading
Background: People living with and beyond breast cancer can face internal barriers to physical activity (eg, fatigue and pain). Digital interventions that promote psychological acceptance and motivation may help this population navigate these barriers….
Continue Reading
Breast cancer diagnoses among women under 50 have steadily risen, particularly in recent years, driven by estrogen-receptor-positive tumors, according to a study by Washington University School of Medicine. The research, spanning 2000 to 2019,…
Continue Reading
Unveiling a concerning surge in breast cancer diagnoses among women under 50, a study led by the Washington University School of Medicine underscores the urgency of understanding this upward trajectory. Analyzing data from over…
Continue Reading
Explore AI’s evolution, challenges, and breakthroughs at RSNA23. Leaders, including Connie Lehman, MD, PhD, Etta D. Pisano, MD, and Fredrik Strand, MSc, MD, PhD, delve into clinical implementation challenges, cutting-edge research outcomes, and regulatory…
Continue Reading
Following a record 95 applications, judges have selected 25 digital health start-ups to advance to the next stage of Digital Health Rewired Pitchfest 2024.Some of the best start-ups from across the UK, Europe, US…
Continue Reading
Detroit-based Karmanos Cancer Institute, a network of 16 treatment locations across Michigan and Ohio that is part of McLaren Health Care, is using artificial intelligence to elevate risk assessment and is surfacing high-risk breast…
Continue Reading
Following a record 95 applications, our judges have chosen 25 digital health start-ups to advance to the next stage of Pitchfest 2024 competition. Some of the best start-ups from the UK, Europe, US and even as…
Continue Reading
The Department of Health and Social Care (DHSC) has said it will take forward a UK National Screening Committee recommendation to increase the use of digital pathology to examine body tissue samples. The use…
Continue Reading
Volpara Health Technologies (Volpara), a global leader in software for the early detection of breast cancer, is pleased to announce it has entered into an agreement to be acquired by Lunit Inc. Under the…
Continue Reading
